Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/220235
A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis.
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: Patient heterogeneity poses significant challenges for managing individuals and designing clinical trials, especially in complex diseases. Existing classifications rely on outcome-predicting scores, potentially overlooking crucial elements contributing to heterogeneity without necessarily impacting prognosis.
Methods: To address patient heterogeneity, we developed ClustALL, a computational pipeline that simultaneously faces diverse clinical data challenges like mixed types, missing values, and collinearity. ClustALL enables the unsupervised identification of patient stratifications while filtering for stratifications that are robust against minor variations in the population (population-based) and against limited adjustments in the algorithm's parameters (parameter-based).
Results: Applied to a European cohort of patients with acutely decompensated cirrhosis (n = 766), ClustALL identified five robust stratifications, using only data at hospital admission. All stratifications included markers of impaired liver function and number of organ dysfunction or failure, and most included precipitating events. When focusing on one of these stratifications, patients were categorized into three clusters characterized by typical clinical features; notably, the 3-cluster stratification showed a prognostic value. Re-assessment of patient stratification during follow-up delineated patients' outcomes, with further improvement of the prognostic value of the stratification. We validated these findings in an independent prospective multicentre cohort of patients from Latin America (n = 580).
Conclusions: By applying ClustALL to patients with acutely decompensated cirrhosis, we identified three patient clusters. Following these clusters over time offers insights that could guide future clinical trial design. ClustALL is a novel and robust stratification method capable of addressing the multiple challenges of patient stratification in most complex diseases.
Matèries
Matèries (anglès)
Citació
Citació
PALOMINO ECHEVERRIA, Sara, HUERGO, Estefania, ORTEGA LEGARRETA, Asier, USON RAPOSO, Eva m., AGUILAR, Ferran, DE LA PEÑA-RAMÍREZ, Carlos, LÓPEZ VICARIO, Cristina, ALESSANDRIA, Carlo, LALEMAN, Wim, QUEIROZ FARIAS, Alberto, MOREAU, Richard, FERNÁNDEZ, Javier, ARROYO, Vicente, CARACENI, Paolo, LAGANI, Vincenzo, SÁNCHEZ GARRIDO, Cristina, CLÀRIA I ENRICH, Joan, TEGNÉR, Jesper, TREBICKA, Jonel, KIANI, Narsis a., PLANELL PICOLA, Núria, RAUTOU, Pierre-emmanuel, GOMEZ CABRERO, David. A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis.. _Journal of Translational Medicine_. 2024. Vol. 22, núm. 1. [consulta: 25 de gener de 2026]. ISSN: 1479-5876. [Disponible a: https://hdl.handle.net/2445/220235]